Found 66 matching trials
CIML NK Cell in Head & Neck Cancer PHASE1 This research study is evaluating the safety and efficacy of a combination ...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer PHASE2 Background:
Immunotherapy is a powerful tool in the fight against cancer. ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer PHASE1 This phase Ib trial will investigate the effect of N-803 in combination wit...
Show More Location
Multiple Locations
Learn More & Join Trial
N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV PHASE1 To assess the safety of combination immune therapy in HIV-infected particip...
Show More Location
University of California
Learn More & Join Trial
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) PHASE1 Background:
Immunotherapy drugs help the body to fight cancer. Scientists ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection PHASE2 Reducing HIV persistence in lymph nodes by Interleukin-15 (IL-15) Receptor ...
Show More Status
Active Not Recruiting
Location
Thai Red Cross AIDS Research Centre
Learn More & Join Trial
Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer PHASE2 This is an open-label, phase 2, randomized study of intravesical N-803 plus...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer PHASE1 This is a Phase Ib/IIb, randomized, two-cohort, open-label, multicenter stu...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy EARLY_PHASE1 This early phase I trial tests the safety and how well N-803 works in treat...
Show More Location
Northwestern University
Learn More & Join Trial
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma PHASE2 This study consists of 2 portions. The phase 2 portion is an open-label, si...
Show More Status
Active Not Recruiting
Location
Chan Soon-Shiong Institute for Medicine (CSSIFM)
Learn More & Join Trial